Trial Profile
Comparing Late Conversion from Tacrolimus to a Belatacept-based Immunosuppression Regime in Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 10 May 2018 New trial record